Thermo Fisher Scientific Inc.

TMO · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.1%

Institutions94.2%

Public / Other

	You	Peer avg
P/E	33.0	51.1
Revenue Growth	+10.5%	+33.9%
ROE	13.5%	13.3%

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$44.56B	$42.88B	$42.86B	$44.91B	$39.21B	$32.22B	$25.54B	$24.36B	$20.92B	$18.27B
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$26.32B	$25.18B	$25.76B	$25.94B	$19.57B	–	$14.21B	$13.50B	$8.98B	$8.21B
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$7.75B	$7.34B	$6.86B	$8.39B	$10.03B	$7.79B	$4.59B	$3.78B	$2.97B	$2.45B
Operating income as a percentage of revenue.	17.4%	17.1%	16.0%	18.7%	25.6%	24.2%	18.0%	15.5%	14.2%	13.4%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$17.00M	$3.00M	-$40.00M	$10.00M	$3.00M	$6.38B	$3.70B	$2.94B	$2.23B	$2.02B
Net income divided by the number of shares outstanding — profit attributable to each share.	$17.77	$16.58	$15.52	$17.75	$19.62	$16.09	$9.24	$7.00	$5.00	$5.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$17.74	$16.53	$15.45	$17.63	$19.46	$15.96	$9.17	$7.00	$5.00	$5.00

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$9.85B	$4.01B	$8.08B	$8.52B	$4.48B	$10.32B	$2.40B	$2.10B	$1.33B	$786.20M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$110.34B	$97.32B	$98.73B	$97.15B	$95.12B	$69.05B	$58.38B	$56.23B	$56.67B	$45.91B
All of the company's interest-bearing borrowings, short and long term combined.	$3.53B	$2.21B	$3.61B	$5.58B	$2.54B	$21.73B	$17.75B	$1.27B	$2.13B	$1.26B
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$53.41B	$49.58B	$46.73B	$43.98B	$40.79B	$34.51B	$29.68B	$27.59B	$25.41B	$21.54B

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$7.82B	$8.67B	$8.41B	$9.15B	$9.31B	$8.29B	$4.97B	$4.54B	$4.00B	$3.16B
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$1.52B	$1.40B	$1.48B	$2.24B	$2.52B	$1.47B	$926.00M	$758.00M	$508.00M	$444.40M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$6.29B	$7.27B	$6.93B	$6.91B	$6.79B	$6.82B	$4.05B	$3.79B	$3.50B	$2.71B

Thermo Fisher Scientific Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Peer Comparison

Income Statement

Balance Sheet

Cash Flow Statement